ApoGlyx (private company)
See something wrong or missing? Let us know
Offices:Lund
Industry:
Biotech
Health services
Business model:
B2B
Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy and concepts for metabolic and inflammatory diseases, f.x. sepsis.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 700k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom